Having trouble viewing this email? View the content as a web page.

HSE Biocides ebulletin

Issued: 21 March 2024

 

This ebulletin contains information on regulating biocides in Great Britain (GB). 

 

The GB Biocidal Products Regulation (GB BPR) operates independently from the EU Biocidal Products Regulation (EU BPR), which applies in Northern Ireland.

 

Separate ebulletins containing information specific to regulating biocides in Northern Ireland are issued as appropriate.

Upcoming GB active substance renewal submission deadlines

Apply for active substance renewal by the deadlines to keep products on the GB market

Under the GB BPR, active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date.

 

The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR:

• 4,5-dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) (CAS 64359-81-5 EC 264-843-8) in product type 21
  29 June 2024
  
  
• Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper (Copper pyrithione) (CAS 14915-37-8 EC 238-984-0) in product type 21
  29 June 2024
  
  
• Copper flakes (coated with aliphatic acids) (CAS 7440-50-8 EC 231-159-6) in product type 21
  29 June 2024
  
  
• Copper thiocyanate (CAS 1111-67-7 EC 214-183-1) in product type 21
  29 June 2024
  
  
• Dichloro-N-[(dimethylamino)sulphonyl] fluoro-N-(ptolyl)methanesulphenamide (Tolylfluanid) (CAS 731-27-1 EC 211-986-9) in product type 21
  29 June 2024
  
  
• Dicopper oxide (CAS 1317-39-1 EC 215-270-7) in product type 21
  29 June 2024
  
  
• N-(dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid) (CAS 1085-98-9 EC 214-118-7) in product type 21
  29 June 2024
  
  
• N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product type 6
  29 June 2024
  
  
• Pythium oligandrum, Chromista - Stramenopila (CAS N/A EC N/A) in product type 10
  29 June 2024
  
  
• Zinc ethylenebis(dithiocarbamate) (polymeric) (Zineb) (CAS 12122-67-7 EC 235-180-1) in product type 21
  29 June 2024
  
  
• (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin) (CAS 210880-92-5 EC 433-460-1) in product type 18
  29 March 2025
  
  
• 2-methyl-2H-isothiazol-3-one (MIT) (CAS 2682-20-4 EC 220-239-6) in product type 13
  29 March 2025
  
  
• Glutaral (Glutaraldehyde) (CAS 111-30-8 EC 203-856-5) in product types 2, 3, 4, 6, 11 and 12
  29 March 2025
  
  
• N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product types 7 and 9
  29 March 2025

Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.

 

Check the GB Article 95 List to see who the original supporters were.

 

If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know.

 

If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances will no longer be able to be used in biocidal products of the relevant product types in GB. In addition articles treated with such products will no longer be able to be placed on the market in GB.

Active substance no longer supported in GB

Non-approval decision to be taken for unsupported active substance in GB

Following an opportunity for any person, company or task force/consortium to support the active substance/product type combination listed below in the GB Review Programme, no compliant notification and dossier were received:

• Silver nitrate (CAS 7761-88-8 EC 231-853-9) in product type 1

In cases where active substance/product type combinations are not supported, GB biocides regulations require that these active substance/product type combinations are subject to a GB non-approval decision.

Once a decision is taken, the active substance will no longer be able to be used in biocidal products of the relevant product type in GB.

 

In addition articles treated with such products will no longer be able to be placed on the market in GB. HSE will provide separate updates on the decision and relevant phase-out periods.

 

Important: If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us by 20 April 2024.